Back to Search Start Over

18F-Fluorosulfate for PET Imaging of the Sodium-Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo.

Authors :
Khoshnevisan A
Chuamsaamarkkee K
Boudjemeline M
Jackson A
Smith GE
Gee AD
Fruhwirth GO
Blower PJ
Source :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Jan; Vol. 58 (1), pp. 156-161. Date of Electronic Publication: 2016 Aug 18.
Publication Year :
2017

Abstract

Anion transport by the human sodium-iodide symporter (hNIS) is an established target for molecular imaging and radionuclide therapy. Current radiotracers for PET of hNIS expression are limited to <superscript>124</superscript> I <superscript>-</superscript> and <superscript>18</superscript> F-BF <subscript>4</subscript> <superscript>-</superscript> We sought new <superscript>18</superscript> F-labeled hNIS substrates offering higher specific activity, higher affinity, and simpler radiochemical synthesis than <superscript>18</superscript> F-BF <subscript>4</subscript> <superscript>-</superscript> METHODS: The ability of a range of anions, some containing fluorine, to block <superscript>99m</superscript> TcO <subscript>4</subscript> <superscript>-</superscript> uptake in hNIS-expressing cells was measured. SO <subscript>3</subscript> F <superscript>-</superscript> emerged as a promising candidate. <superscript>18</superscript> F-SO <subscript>3</subscript> F <superscript>-</superscript> was synthesized by reaction of <superscript>18</superscript> F <superscript>-</superscript> with SO <subscript>3</subscript> -pyridine complex in MeCN and purified using alumina and quaternary methyl ammonium solid-phase extraction cartridges. Chemical and radiochemical purity and serum stability were determined by radiochromatography. Radiotracer uptake and efflux in hNIS-transduced HCT116-C19 cells and the hNIS-negative parent cell line were evaluated in vitro in the presence and absence of a known competitive inhibitor (NaClO <subscript>4</subscript> ). PET/CT imaging and ex vivo biodistribution measurement were conducted on BALB/c mice, with and without NaClO <subscript>4</subscript> inhibition.<br />Results: Fluorosulfate was identified as a potent inhibitor of <superscript>99m</superscript> TcO <subscript>4</subscript> <superscript>-</superscript> uptake via hNIS in vitro (half-maximal inhibitory concentration, 0.55-0.56 μM (in comparison with 0.29-4.5 μM for BF <subscript>4</subscript> <superscript>-</superscript> , 0.07 μM for TcO <subscript>4</subscript> <superscript>-</superscript> , and 2.7-4.7 μM for I <superscript>-</superscript> ). Radiolabeling to produce <superscript>18</superscript> F-SO <subscript>3</subscript> F <superscript>-</superscript> was simple and afforded high radiochemical purity suitable for biologic evaluation (radiochemical purity > 95%, decay-corrected radiochemical yield = 31.6%, specific activity ≥ 48.5 GBq/μmol). Specific, blockable hNIS-mediated uptake in HCT116-C19 cells was observed in vitro, and PET/CT imaging of normal mice showed uptake in thyroid, salivary glands (percentage injected dose/g at 30 min, 563 ± 140 and 32 ± 9, respectively), and stomach (percentage injected dose/g at 90 min, 68 ± 21).<br />Conclusion: Fluorosulfate is a high-affinity hNIS substrate. <superscript>18</superscript> F-SO <subscript>3</subscript> F <superscript>-</superscript> is easily synthesized in high yield and very high specific activity and is a promising candidate for preclinical and clinical PET imaging of hNIS expression and thyroid-related disease; it is the first example of in vivo PET imaging with a tracer containing an S- <superscript>18</superscript> F bond.<br /> (© 2017 by the Society of Nuclear Medicine and Molecular Imaging.)

Details

Language :
English
ISSN :
1535-5667
Volume :
58
Issue :
1
Database :
MEDLINE
Journal :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Type :
Academic Journal
Accession number :
27539841
Full Text :
https://doi.org/10.2967/jnumed.116.177519